Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.

Diabetes · 2013 · PMC3717832 · PMID 23630299

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

3 B , left panel) showed that whole pancreatic glucagon protein content was lower in the diabetic SSTR2a group (11.94 ± 0.67 ng/mg protein) compared with the diabetic vehicle group (18.28 ± 1.36 ng/mg protein; P < 0.001), and tended to be lower compared with the nondiabetic groups, although these differences failed to reach statistical significance after adjusting for multiple comparisons.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.